Literature DB >> 23678466

QSAR models for the prediction of plasma protein binding.

Taravat Ghafourian1, Zeshan Amin.   

Abstract

INTRODUCTION: The prediction of plasma protein binding (ppb) is of paramount importance in the pharmacokinetics characterization of drugs, as it causes significant changes in volume of distribution, clearance and drug half life. This study utilized Quantitative Structure - Activity Relationships (QSAR) for the prediction of plasma protein binding.
METHODS: Protein binding values for 794 compounds were collated from literature. The data was partitioned into a training set of 662 compounds and an external validation set of 132 compounds. Physicochemical and molecular descriptors were calculated for each compound using ACD labs/logD, MOE (Chemical Computing Group) and Symyx QSAR software packages. Several data mining tools were employed for the construction of models. These included stepwise regression analysis, Classification and Regression Trees (CART), Boosted trees and Random Forest.
RESULTS: Several predictive models were identified; however, one model in particular produced significantly superior prediction accuracy for the external validation set as measured using mean absolute error and correlation coefficient. The selected model was a boosted regression tree model which had the mean absolute error for training set of 13.25 and for validation set of 14.96.
CONCLUSION: Plasma protein binding can be modeled using simple regression trees or multiple linear regressions with reasonable model accuracies. These interpretable models were able to identify the governing molecular factors for a high ppb that included hydrophobicity, van der Waals surface area parameters, and aromaticity. On the other hand, the more complicated ensemble method of boosted regression trees produced the most accurate ppb estimations for the external validation set.

Keywords:  ADME; Albumin Binding; Distribution; Protein Binding; QSAR; Serum Proteins

Year:  2013        PMID: 23678466      PMCID: PMC3648908          DOI: 10.5681/bi.2013.011

Source DB:  PubMed          Journal:  Bioimpacts        ISSN: 2228-5652


  12 in total

1.  VolSurf: a new tool for the pharmacokinetic optimization of lead compounds.

Authors:  G Cruciani; M Pastor; W Guba
Journal:  Eur J Pharm Sci       Date:  2000-10       Impact factor: 4.384

2.  Cheminformatic models to predict binding affinities to human serum albumin.

Authors:  G Colmenarejo; A Alvarez-Pedraglio; J L Lavandera
Journal:  J Med Chem       Date:  2001-12-06       Impact factor: 7.446

3.  Predicting plasma protein binding of drugs: a new approach.

Authors:  Nicole A Kratochwil; Walter Huber; Francis Müller; Manfred Kansy; Paul R Gerber
Journal:  Biochem Pharmacol       Date:  2002-11-01       Impact factor: 5.858

4.  Evaluation of serum protein binding by using in vitro pharmacological activity for the effective pharmacokinetics profiling in drug discovery.

Authors:  Yukinori Kawai; Yoshimine Fujii; Katsuya Akimoto; Masayuki Takahashi
Journal:  Chem Pharm Bull (Tokyo)       Date:  2010-08       Impact factor: 1.645

5.  QSAR modeling of human serum protein binding with several modeling techniques utilizing structure-information representation.

Authors:  Joseph R Votano; Marc Parham; L Mark Hall; Lowell H Hall; Lemont B Kier; Scott Oloff; Alexander Tropsha
Journal:  J Med Chem       Date:  2006-11-30       Impact factor: 7.446

6.  QSPR models for the prediction of apparent volume of distribution.

Authors:  Taravat Ghafourian; Mohammad Barzegar-Jalali; Siavoush Dastmalchi; Tina Khavari-Khorasani; Nasim Hakimiha; Ali Nokhodchi
Journal:  Int J Pharm       Date:  2006-04-07       Impact factor: 5.875

Review 7.  Significance of protein binding in pharmacokinetics and pharmacodynamics.

Authors:  Stephan Schmidt; Daniel Gonzalez; Hartmut Derendorf
Journal:  J Pharm Sci       Date:  2010-03       Impact factor: 3.534

Review 8.  Determination of human serum alpha1-acid glycoprotein and albumin binding of various marketed and preclinical kinase inhibitors.

Authors:  Ferenc Zsila; Ilona Fitos; Gyula Bencze; György Kéri; László Orfi
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

9.  A new drug binding subsite on human serum albumin and drug-drug interaction studied by X-ray crystallography.

Authors:  Lili Zhu; Feng Yang; Liqing Chen; Edward J Meehan; Mingdong Huang
Journal:  J Struct Biol       Date:  2007-12-28       Impact factor: 2.867

Review 10.  Development of quantitative structure-pharmacokinetic relationships.

Authors:  J M Mayer; H van de Waterbeemd
Journal:  Environ Health Perspect       Date:  1985-09       Impact factor: 9.031

View more
  12 in total

1.  Global Sensitivity Analysis of the Rodgers and Rowland Model for Prediction of Tissue: Plasma Partitioning Coefficients: Assessment of the Key Physiological and Physicochemical Factors That Determine Small-Molecule Tissue Distribution.

Authors:  Estelle Yau; Andrés Olivares-Morales; Michael Gertz; Neil Parrott; Adam S Darwich; Leon Aarons; Kayode Ogungbenro
Journal:  AAPS J       Date:  2020-02-03       Impact factor: 4.009

2.  Designing QSARs for Parameters of High-Throughput Toxicokinetic Models Using Open-Source Descriptors.

Authors:  Daniel E Dawson; Brandall L Ingle; Katherine A Phillips; John W Nichols; John F Wambaugh; Rogelio Tornero-Velez
Journal:  Environ Sci Technol       Date:  2021-04-15       Impact factor: 9.028

3.  Structure-biological function relationship extended to mitotic arrest-deficient 2-like protein Mad2 native and mutants-new opportunity for genetic disorder control.

Authors:  Speranta Avram; Adina Milac; Maria Mernea; Dan Mihailescu; Mihai V Putz; Catalin Buiu
Journal:  Int J Mol Sci       Date:  2014-11-18       Impact factor: 5.923

4.  Developing a Physiologically-Based Pharmacokinetic Model Knowledgebase in Support of Provisional Model Construction.

Authors:  Jingtao Lu; Michael-Rock Goldsmith; Christopher M Grulke; Daniel T Chang; Raina D Brooks; Jeremy A Leonard; Martin B Phillips; Ethan D Hypes; Matthew J Fair; Rogelio Tornero-Velez; Jeffre Johnson; Curtis C Dary; Yu-Mei Tan
Journal:  PLoS Comput Biol       Date:  2016-02-12       Impact factor: 4.475

5.  Modeling Physico-Chemical ADMET Endpoints with Multitask Graph Convolutional Networks.

Authors:  Floriane Montanari; Lara Kuhnke; Antonius Ter Laak; Djork-Arné Clevert
Journal:  Molecules       Date:  2019-12-21       Impact factor: 4.411

6.  Folate-Targeted Curcumin-Loaded Niosomes for Site-Specific Delivery in Breast Cancer Treatment: In Silico and In Vitro Study.

Authors:  Banafsheh Honarvari; Sara Karimifard; Niyayesh Akhtari; Mehrnoush Mehrarya; Zahra Salehi Moghaddam; Mohammad Javed Ansari; Abduladheem Turki Jalil; Adrián Matencio; Francesco Trotta; Faten Eshrati Yeganeh; Bahareh Farasati Far; Mandana Kazem Arki; Mohammad Reza Naimi-Jamal; Hassan Noorbazargan; Zahra Asghari Lalami; Mohsen Chiani
Journal:  Molecules       Date:  2022-07-20       Impact factor: 4.927

7.  Prioritization of anti-malarial hits from nature: chemo-informatic profiling of natural products with in vitro antiplasmodial activities and currently registered anti-malarial drugs.

Authors:  Samuel Ayodele Egieyeh; James Syce; Sarel F Malan; Alan Christoffels
Journal:  Malar J       Date:  2016-01-29       Impact factor: 2.979

8.  Computational analysis of eugenol inhibitory activity in lipoxygenase and cyclooxygenase pathways.

Authors:  Francisco das Chagas Pereira de Andrade; Anderson Nogueira Mendes
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

9.  Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19).

Authors:  Amr El-Demerdash; Ahmed M Metwaly; Afnan Hassan; Tarek Mohamed Abd El-Aziz; Eslam B Elkaeed; Ibrahim H Eissa; Reem K Arafa; James D Stockand
Journal:  Biomolecules       Date:  2021-03-19

10.  Potential DPP IV Inhibitory Peptides from Dry-Cured Pork Loins after Hydrolysis: An In Vitro and In Silico Study.

Authors:  Paulina Kęska; Joanna Stadnik
Journal:  Curr Issues Mol Biol       Date:  2021-09-27       Impact factor: 2.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.